AI Article Synopsis
- * In a trial with 20 patients, the FuStar sheath successfully facilitated LAAO with the LAmbre device, achieving a 100% success rate without any complications.
- * Overall, the results indicate that the FuStar sheath is both feasible and safe for performing LAAO procedures.
Article Abstract
Background: Due the wide variability of left atrial appendage morphology left atrial appendage occlusion (LAAO) remains a challenging procedure. The steerable FuStar delivery sheath was designed to allow both, transseptal access and delivery of percutaneous devices. We here report the first-in-human experience of LAAO with the FuStar sheath.
Methods: Twenty patients (76.6 ± 8.4 years; 12 (60%) males; CHA DS -VASc score: 5.0 ± 2) with non-valvular fibrillation and contraindications to oral anticoagulation underwent LAAO with the LAmbre device using the FuStar steerable sheath (Lifetech Scientific Corp., Shenzhen, China) at two german centers.
Results: Successful device implantation was achieved in all patients (100%). No periprocedural complications were observed. Procedure time, fluoroscopy time, contrast media, and radiation dose were 23.4 min ± 9.2, 11.9 min ± 4.1, 96.2 mL ± 45.7, and 2718.4 cG*cm ± 3835.3, respectively.
Conclusion: This study demonstrates the feasibility and safety of the steerable FuStar sheath for LAAO.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/joic.12509 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!